Koch, Philipp https://orcid.org/0009-0008-5508-4500
Zhang, Zijian https://orcid.org/0009-0009-0938-1798
Genuth, Naomi R https://orcid.org/0000-0003-2240-1318
Susanto, Teodorus Theo https://orcid.org/0000-0002-5537-3360
Haimann, Martin https://orcid.org/0009-0007-8686-9530
Khmelinskaia, Alena https://orcid.org/0000-0003-1584-9800
Byeon, Gun Woo https://orcid.org/0000-0001-5022-4342
Dey, Saurabh https://orcid.org/0000-0003-1432-3823
Barna, Maria https://orcid.org/0000-0002-6843-4396
Leppek, Kathrin https://orcid.org/0000-0002-8012-8076
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (216372545)
Deutsche Forschungsgemeinschaft (EXC2151)
HHS | National Institutes of Health (R01-GM129325)
HHS | National Institutes of Health (5R01HD086634)
HHS | National Institutes of Health (P50 training grant)
Rosetta Commons Mini Grant (RC22025)
Agency for Science, Technology and Research (National Science Scholarship (Ph.D.))
National Science Foundation (Graduate Research Fellowship DGE-114747)
University of Bonn, TRA (Life and Health Research Prize 2024)
University of Bonn, STEP (PhD Position)
University of Bonn, University Clinic Bonn (start-up funds)
Article History
Received: 26 May 2024
Revised: 26 January 2025
Accepted: 18 February 2025
First Online: 13 March 2025
Disclosure and competing interests statement
: KL and MB are inventors of patents related to the Hoxa9 P4 stem-loop and RNA therapeutics and their various uses. PK, MB, and KL are inventors on a patent related to IRES-like elements in circRNA reporters and RNA therapeutics and their various uses. The remaining authors declare no competing interests.